Table 1 Participant baseline characteristics & follow-up encounters (N = 84)
Demographic characteristic | Whole sample (N = 84 unless stated otherwise) | Respondents to at least 1 survey (N = 60 unless stated otherwise) | Non-respondents (N = 24 unless stated otherwise) |
|---|---|---|---|
Median age (years) | 33 [IQR 28—40.3] | 32.5 [IQR 29.5- 41] | 32 [IQR 25.8 – 38] |
Female (%) (1 respondent identified as other, the remainder as male) | 24/84 (29%) | 18/60 (30%) | 6/24 (25%) |
Identify as Indigenous or part Indigenous (%) | 28/82 (34%) | 19/58 (33%) | 9/24 (38%) |
Injection opioid use (%) | 56/84 (67%) | 42/60 (70%) | 14/24 (58%) |
Median baseline treatment motivation score (7-point scale) | 5 [IQR 3.5–7] (N = 79) | 5 [IQR 4–6.5] (N = 55) | 5 [IQR 3–7] |
Median Euroqol score | 50 [IQR 30–70] (N = 83) | 50 [IQR 30–70] (N = 59) | 47.5 [IQR 30–70] |
Fixed housing (%) | 27/84 (32%) | 24/60 (40%) | 3/24 (12%) |
Employed (%) | 5/84 (6%) | 4/60 (7%) | 1/24 (4%) |
Baseline engagement in care (%) | 18/81 (22%) | 13/58 (22%) | 5/23 (22%) |
Median anticipated helpfulness of outreach at baseline (7-point scale) | 6 [IQR 5–7] (N = 83) | 6 [IQR 5–7] (N = 59) | 6 [IQR 5–7] |
Median outreach team encounters in 1 year | 3 [IQR 1–5.25] (Range 0–17) | 4 [IQR 2–7] (Range 1–17) | 0 [IQR 0–1] (Range 0–10) |
Any outreach encounter | 70/84 (83%) | 60/60 (100%) | 10/24 (42%) |